Tech Company Financing Transactions
Purigen Biosystems Funding Round
Purigen Biosystems closed a $18.2 million Series A funding round on 5/18/2016. Investors included 5AM Ventures, Roche Venture Fund and StartX.
Transaction Overview
Company Name
Announced On
5/18/2016
Transaction Type
Venture Equity
Amount
$18,200,000
Round
Series A
Investors
Proceeds Purpose
The Series A proceeds will be used to accelerate research, development and commercialization of the Purigen benchtop technology, which involves the automated extraction and quantification of samples for genomic and genetic testing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5700 Stoneridge Dr. 100
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
Purigen Biosystems is redefining nucleic acid sample prep by providing an innovative platform based on the remarkably efficient isotachophoresis technology invented in the lab of Stanford University professor Juan Santiago.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barney Saunders
Chief Financial Officer
Steve Reichenbach
Chief Scientific Officer
Klint Rose
Co-Founder
Juan Santiago
VP - Operations
Pam Delucchi
VP - Sales
Chris Grimley
Browse more venture capital transactions:
Prev: 5/18/2016: Mesitis venture capital transaction
Next: 5/18/2016: Lucid Sight venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs